References

  1. Gelband H, Jha P, Sankaranarayanan R, Horton S (eds). Cancer: disease control priorities (Volume 3): third Edition. 2015 Washington (DC). The World Bank Publications. PubMed | Google Scholar

  2. Tshomo U, Franceschi S, Tshokey T, Tobgay T, Baussano I, Tenet V et al. Evaluation of cyto-logy versus human papillomavirus-based cervical cancer screening algorithms in Bhutan. On-cotarget. 2017; 8(42): 72438-72446. PubMed | Google Scholar

  3. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006; 24(Suppl3):S3/71-7. PubMed | Google Scholar

  4. Nour NM. Cervical cancer: a preventable death. Rev Obstet Gynecol. 2009; 2(4): 240-4. PubMed | Google Scholar

  5. Marlow LA, Wardle J, Waller J. Understanding cervical screening non-attendance among ethnic minority women in England. Br J Cancer. 2015; 113(5): 833-9. PubMed | Google Scholar

  6. Enerly E, Bonde J, Schee K, Pedersen H, Lönnberg S, Nygĺrd M. Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme. PLoS One. 2016; 11(4): e0151978. PubMed | Google Scholar

  7. Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer. 2012; 130(8): 1855-60. PubMed | Google Scholar

  8. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases Report. 2nd July 2017. Accessed on Mar 2018.

  9. Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJF et al. Human papillo-mavirus infection in women with and without cervical cancer in Ibadan Nigeria. Infect Agent Cancer. 2010; 5: 24. PubMed | Google Scholar

  10. Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M et al. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. Int J Cancer. 2012; 130(9): 2111-2117. PubMed | Google Scholar

  11. Nweke IG, Banjo AAF, Abdulkareem FB, Nwadike VU. Prevalence of Human Papilloma Virus DNA in HIV Positive Women in Lagos University Teaching Hospital (LUTH) Lagos Ni-geria. BMRJ. 2013; 3(3): 400-413. Google Scholar

  12. Manga MM, Fowotade A, Abdullahi YM, El-Nafaty AU, Adamu DB, Pindiga HU et al. Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infect Agent Cancer. 2015; 10(1): 39. PubMed | Google Scholar

  13. Auwal IK, Aminu M, Atanda AT, Tukur J, Sarkinfada F. Prevalence and Risk Factors of High Risk Human Papillomavirus Infections among Women Attending Gynaecology Clinics in Kano Northern Nigeria. Bayero J Pure Appl Sci. 2014; 6(1): 67-71. Google Scholar

  14. Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W et al. Comparison of the perfor-mance of different HPV genotyping methods for detecting genital HPV types. J Med Virol. 2008; 80(7): 1264-74. PubMed | Google Scholar

  15. Tsiodras S, Georgoulakis J, Chranioti A, Voulgaris Z, Psyrri A, Tsivilika A et al. Hybrid capture vs PCR screening of cervical human papilloma virus infections: cytological and histological associations in 1270 women. BMC Cancer. 2010; 10: 53. PubMed | Google Scholar

  16. Modibbo F, Iregbu KC, Okuma J, Leeman A, Kasius A, de Koning M et al. Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria. Infect Agent Cancer. 2017; 12: 11. PubMed | Google Scholar

  17. Rahman M, Sasagawa T, Yamada R, Kingoro A, Ichimura H, Makinoda S. High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women in-fected with human immunodeficiency virus. J Med Virol. 2011; 83(11): 1988-96. PubMed | Google Scholar

  18. Balanda M, Quiero A, Vergara N, Espinoza G, Martín HS, Rojas G et al. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Med Microbiol Immunol. 2016; 205(6): 585-594. PubMed | Google Scholar

  19. Baloch Z, Li Y, Yuan T, Feng Y, Liu Y, Tai W et al. Epidemiologic characterization of hu-man papillomavirus (HPV) infection in various regions of Yunnan Province of China. BMC In-fect Dis. 2016; 16: 228. PubMed | Google Scholar

  20. Orozco-Colín A, Carrillo-García A, Méndez-Tenorio A, Ponce-de-León S, Mohar A, Maldonado-Rodríguez R et al. Geographical variation in human papillomavirus prevalence in Mexi-can women with normal cytology. Int J Infect Dis. 2010; 14(12): e1082-7. PubMed | Google Scholar

  21. De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epi-demiol Biomarkers Prev. 2008; 17(8): 2163-8. PubMed | Google Scholar

  22. Cw N, Boga H, Aw M, Wanzala P, Jn M. Factors affecting uptake of Cervical Cancer Early Detection measures among women in Thika Kenya. Health Care For Women International. 2012; 33(7): 595-613. Google Scholar

  23. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J. Vaginal self sampling versus physi-cian cervical sampling for HPV among younger and older women. Sex Transm Infect. 2006; 82(4): 337-9. PubMed | Google Scholar

  24. Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical sam-ples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol. 2009; 33(6): 446-50. PubMed | Google Scholar

  25. Seo SS, Song YS, Kim JW, Park NH, Kang SB, Lee HP. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleo-tide microarray. Gynecol Oncol. 2006; 102(1): 67-73. PubMed | Google Scholar

  26. Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M et al. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai Uganda. Sex Transm Dis. 2007; 34(7): 429-36. PubMed | Google Scholar